Furthermore, IL-32 is expressed by PBMC of patients with heart failure and seric IL-32 concentrations have been positively correlated with cardiac fibrosis and poor outcomes after myocardial infarction [80], strongly suggesting its contribution to cardiac remodeling, through NFκB activation. Here, NFKB1 is linked to heart failure.